BANK OF MONTREAL /CAN/ - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$39,000
-61.0%
31,595
-2.2%
0.00%
Q1 2017$100,000
-45.7%
32,308
-3.5%
0.00%
Q4 2016$184,000
-15.2%
33,482
-1.8%
0.00%
Q3 2016$217,000
+197.3%
34,087
+154.7%
0.00%
Q2 2016$73,000
-13.1%
13,383
+32.4%
0.00%
Q1 2016$84,000
+5.0%
10,1050.0%0.00%
Q4 2015$80,000
-4.8%
10,105
+2.5%
0.00%
Q3 2015$84,000
-11.6%
9,859
+28.0%
0.00%
Q2 2015$95,000
+3.3%
7,7000.0%0.00%
Q1 2015$92,000
+5.7%
7,7000.0%0.00%
Q4 2014$87,000
+27.9%
7,7000.0%0.00%
Q3 2014$68,000
+15.3%
7,700
-5.8%
0.00%
Q2 2014$59,000
+103.4%
8,170
+40.9%
0.00%
Q1 2014$29,000
+61.1%
5,800
+65.7%
0.00%
Q4 2013$18,000
+38.5%
3,5000.0%0.00%
Q3 2013$13,000
+85.7%
3,500
+250.0%
0.00%
Q2 2013$7,0001,0000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders